
Jason Litten
Chief Medical Officer · GENELUX Corp
- 2026
- Jan 7, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Litten files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas Zindrick - $184K in GNLX purchases and sales in the last 12 months
- John Thomas - $109K in GNLX purchases and sales in the last 12 months
- Yong Yu - $49K in GNLX purchases and sales in the last 12 months
- Joseph Cappello - $48K in GNLX purchases and sales in the last 12 months
- John W. Smither - $35K in GNLX purchases and sales in the last 12 months
- Ralph Smalling - $12K in GNLX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Litten?
Jason Litten is a corporate insider, tracked as Chief Medical Officer of GENELUX Corp (GNLX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jason Litten last file a Form 4?
The only primary Form 4 on record is dated 7 January 2026.